Anzeige
Mehr »
Login
Sonntag, 26.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Der SILBER-STURM kommt - wie diese unterbewertete Firma die Investmentwelt aufmischt und Milliardenwerte hebt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Übersicht Suchergebnisse zum Thema NEVRO

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
FrNevro Corp.: Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08307REDWOOD CITY, Calif., May 24, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic...
► Artikel lesen
MiCiti upgrades Edwards, Tandem; cuts Nevro, Establishment Labs2
10.05.Nevro promotes new chief operating officer from within1
08.05.Assessing Nevro: Insights From 9 Financial Analysts2
08.05.Nevro Corp. (NVRO) Q1 2024 Earnings Call Transcript1
08.05.Nevro's (NVRO) Q1 Earnings and Sales Beat Estimates, Margins Up1
07.05.Nevro Corp reports results for the quarter ended in March - Earnings Summary1
07.05.NEVRO CORP - 10-Q, Quarterly Report-
07.05.NEVRO CORP - 8-K, Current Report-
07.05.Nevro Corp.: Nevro Reports First-Quarter 2024 Financial Results60Announces Additional Restructuring Steps to Advance Strategy and Accelerate Profitability Raises Adjusted EBITDA Guidance and Reaffirms Revenue Guidance for Full-Year 2024 Promotes Christofer Christoforou...
► Artikel lesen
25.04.NEVRO CORP - 8-K, Current Report3
03.04.Where Nevro Stands With Analysts3
21.03.Here's Why You Should Retain Nevro (NVRO) Stock for Now1
29.02.Nevro (NVRO) Gets FDA Nod for SI Fixation Without Lateral Screw3
28.02.FDA clears Nevro SI joint device without need for lateral screw3
28.02.FDA clears sacroiliac joint fusion device from Nevro2
23.02.NEVRO CORP - S-8, Securities to be offered to employees in employee benefit plans1
23.02.Nevro Corp reports results for the quarter ended in December - Earnings Summary1
23.02.Why Nevro Stock Lagged the Market on Thursday1
22.02.Oppenheimer cuts Nevro to perform, cites weakness in core business1
Seite:  Weiter >>